ORMP
Oramed Pharmaceuticals Inc
Price:  
2.18 
USD
Volume:  
122,267.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

ORMP WACC - Weighted Average Cost of Capital

The WACC of Oramed Pharmaceuticals Inc (ORMP) is 6.9%.

The Cost of Equity of Oramed Pharmaceuticals Inc (ORMP) is 7.80%.
The Cost of Debt of Oramed Pharmaceuticals Inc (ORMP) is 7.00%.

Range Selected
Cost of equity 6.40% - 9.20% 7.80%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 7.00% - 7.00% 7.00%
WACC 6.0% - 7.8% 6.9%
WACC

ORMP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.55 0.78
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.40% 9.20%
Tax rate 26.20% 27.00%
Debt/Equity ratio 0.54 0.54
Cost of debt 7.00% 7.00%
After-tax WACC 6.0% 7.8%
Selected WACC 6.9%